Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
57.34 USD | -1.76% | -5.68% | -8.68% |
Mar. 12 | Incyte's Povorcitinib Potentially Suited for Hidradenitis Suppurativa, Prurigo Nodularis, RBC Says | MT |
Mar. 11 | Transcript : Incyte Corporation - Shareholder/Analyst Call |
- Stock
- Equities
- Stock Incyte Corporation - Nasdaq
- News Incyte Corporation